Literature DB >> 7906658

Acute fluvoxamine poisoning.

R Garnier1, P Azoyan, D Chataigner, P Taboulet, D Dellattre, M L Efthymiou.   

Abstract

A total of 221 cases of deliberate acute overdose with fluvoxamine reported to the Paris Poison Centre, and 78 cases collected by the International Drug Safety Department of Duphar BV were analysed. Other agents, mainly benzodiazepines, neuroleptics, other antidepressants and alcohol, were also taken in 77% of the cases. The acute toxicity that could be attributed to fluvoxamine alone was rarely severe. The symptoms observed were always benign when the dose of fluvoxamine was below 1000 mg and included drowsiness, tremor, nausea, vomiting, abdominal pain, bradycardia and/or anticholinergic effects (dry mouth, mydriasis, sinus tachycardia, urinary retention). Seizures occurred in a few cases after high doses (generally > 1500 mg). Cardiotoxicity was not a serious problem; sinus bradycardia was noted with doses of less than 1000 mg, but was always moderate and required no treatment. Conduction abnormalities were rare.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906658     DOI: 10.1177/030006059302100405

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  9 in total

Review 1.  The use of psychotropics in the medically ill.

Authors:  M J Robinson; J L Levenson
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

2.  Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone.

Authors:  M Gallerani; L Grassi; F Ferrari; G Calò; R Manfredini
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 3.  Drug-induced urinary retention: incidence, management and prevention.

Authors:  Katia M C Verhamme; Miriam C J M Sturkenboom; Bruno H Ch Stricker; Ruud Bosch
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Refractory status epilepticus, circulatory collapse after cardiac arrest, and acute respiratory distress syndrome caused by severe isolated fluvoxamine poisoning: a case report.

Authors:  Tomomichi Kan'o; Yoshihito Kamijo; Jun Hattori; Fumie Kashimi; Chie Sato; Kuniko Yoshimura
Journal:  Acute Med Surg       Date:  2014-06-26

5.  Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Authors:  J G Edwards; I Anderson
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 6.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 7.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 8.  Recent Advances in Quenchbody, a Fluorescent Immunosensor.

Authors:  Jinhua Dong; Hiroshi Ueda
Journal:  Sensors (Basel)       Date:  2021-02-09       Impact factor: 3.576

9.  Fluvoxamine in the treatment of anxiety disorders.

Authors:  Jane Irons
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.